Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 601 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer
Khushboo A. Gandhi, Aditi Shirsat, Sharat Kumar HJ, Ashish Chavan, Parnika Dicholkar, Saniya Shah,Nandini Menon,Vanita Noronha,Amit Joshi,Kumar Prabhash,Vijay Patil,Vikram Gota
Cancer Chemotherapy and Pharmacologypp.1-10, (2024)
Cited0Views0WOSBibtex
0
0
Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained Settings
Amit Kumar, Akhil Kapoor,Vanita Noronha,Vijay M. Patil, Amit Joshi,Nandini Menon,Amit Janu, Abhishek Mahajan,Akhil Rajendra, Amit Agarawal,Satvik Khaddar, Anu Rajpurohit,Lakhan Kashyap, Anne Srikant, Gautam Panda, Kishore Kumar Kota,Vikas Talreja,Kumar Prabhash
SOUTH ASIAN JOURNAL OF CANCER (2024)
Cited0Views0Bibtex
0
0
Uniqueness of Lung Cancer in Southeast Asia
Vanita Noronha,Atul Budukh,Pankaj Chaturvedi, Srikanth Anne, Anshu Punjabi,Maheema Bhaskar,Tarini P. Sahoo,Nandini Menon,Minit Shah,Ullas Batra,Shrinidhi Nathany,Rajiv Kumar,Omshree Shetty,Trupti Pai Ghodke,Abhishek Mahajan,Nivedita Chakrabarty,Supriya Hait,Satyendra C. Tripathi,Anuradha Chougule,Pratik Chandrani, Virendra Kumar Tripathi,Sabita Jiwnani,Anil Tibdewal, Guncha Maheshwari,Rushabh Kothari,Vijay M. Patil, Rajani Surendar Bhat, Mansi Khanderia, Vandana Mahajan, Ravi Prakash, Sanjeev Sharma, Adnan Abdul Jabbar, Birendra Kumar Yadav, A. F. M. Kamal Uddin,Amit Dutt, Kumar Prabhasha
LANCET REGIONAL HEALTH - SOUTHEAST ASIA (2024)
Cited0Views0WOSBibtex
0
0
VAMANA: A Phase 2 Study of Low-Dose Bevacizumab Plus CCNU in Relapsed/recurrent Glioblastoma
Nandini Menon, Minit Shah,Tejpal Gupta,Sridhar Epari, Abhishek Chatterjee,Archya Dasgupta,Arpita Sahu, Riddhi Sawant, Venkatesh Kapu, Mehak Trikha, Ajit Shah, Zoya Peelay,Ameya Puranik,Indraja Dev, Monica Jadhav,Aliasgar Moiyadi, Prakash Shetty,Ayushi Sahay, Vikas Kumar Singh,Vijay Maruti Patil
Journal of clinical oncologyno. 17_suppl (2024): LBA2064-LBA2064
Cited0Views0Bibtex
0
0
Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) Followed by Docetaxel Versus Oxaliplatin-Capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative Advanced Gastric Cancers
Anant Ramaswamy,Prabhat Bhargava, Biswajit Dubashi,Anuj Gupta, Akhil Kapoor,Sujay Srinivas,Omshree Shetty, Poonam Jadhav, Veena Desai,Vanita Noronha,Amit Joshi,Nandini Menon,Vijay M. Patil, Bal Krishna Mishra, Bipinesh Sansar, Arpita Singh,Swapnil Patel, Satyendra Narayan Singh, Ipsita Dhal, Kunal Ranjan Vinayak, Vikash Pal,Sarika Mandavkar, Sadhana Kannan,Deepali Chaugule, Rajshree Patil, Manali Parulekar,Chaitali Nashikkar,Suman Kumar Ankathi,Rajiv Kumar Kaushal,Aekta Shah, Prasanth Ganesan,Smita Kayal, Ramesh Ananthakrishnan, Noorzia Syed, Debdeep Samaddar, Venkatesh Kapu, Anokhi Shah, D. Kaaviya, R. Suganiya, Nirmala Devi Srinivasan,Kumar Prabhash, Vikas Ostwal
JNCI CANCER SPECTRUMno. 4 (2024)
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 599

#Citation: 3587

H-Index: 27

G-Index: 48

Sociability: 7

Diversity: 0

Activity: 9

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn